DNA X, Inc.
SONM
$4.75
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.40M | 44.13M | 59.11M | 57.92M | 58.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.40M | 44.13M | 59.11M | 57.92M | 58.24M |
| Cost of Revenue | 24.74M | 24.74M | 24.74M | 21.14M | 22.55M |
| Gross Profit | 2.66M | 2.66M | 2.66M | 5.08M | 3.98M |
| SG&A Expenses | 8.15M | 5.41M | -440.00K | -162.00K | -1.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.15M | 5.41M | -12.76M | -15.56M | -15.50M |
| Operating Income | -8.15M | -5.41M | -3.15M | -1.54M | -1.28M |
| Income Before Tax | -10.92M | -7.96M | -4.09M | -1.82M | -1.06M |
| Income Tax Expenses | 229.00K | 229.00K | 229.00K | 256.00K | 154.00K |
| Earnings from Continuing Operations | -10.92 | -7.96 | -4.04 | -1.80 | -0.94 |
| Earnings from Discontinued Operations | -3.85M | -12.70M | 1.42M | 1.42M | 1.42M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.78M | -20.66M | -33.38M | -31.14M | -30.28M |
| EBIT | -8.15M | -5.41M | -3.15M | -1.54M | -1.28M |
| EBITDA | -3.83M | -1.11M | 571.00K | 2.14M | 2.45M |
| EPS Basic | -23.33 | -26.93 | -99.43 | -103.93 | -115.20 |
| Normalized Basic EPS | -6.48 | -6.39 | 8.73 | 6.13 | -1.69 |
| EPS Diluted | -23.34 | -26.94 | -99.51 | -104.00 | -115.20 |
| Normalized Diluted EPS | -6.48 | -6.39 | 8.73 | 6.13 | -1.69 |
| Average Basic Shares Outstanding | 3.50M | 2.56M | 2.10M | 1.38M | 1.12M |
| Average Diluted Shares Outstanding | 3.50M | 2.56M | 2.10M | 1.38M | 1.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |